Global shortage of two key treatments
Manx Care says there’s 'no immediate threat' to stroke patients, and those with heart conditions, due to a global shortage of two key treatments.
The Isle of Man, along with UK NHS trusts, is being asked to conserve supplies of two drugs - Alteplase and Tenecteplase - due to manufacturer issues.
The shortage is expected to last until early next year and hospitals are being asked to provide alternative treatments where appropriate.
Dr Sreeman Andole is the executive medical director, and stroke consultant, at Noble's Hospital:
Isle of Man falls silent on Remembrance Sunday
MHK urges inclusion of 'commencement clause' in bill removing Bishop's vote
Drug dealer found with cocaine worth £13k jailed
Glamping plan submitted for Ramsey Rugby Club during TT